Top 5 COVID-19 vaccine questions answered

Nobel’s next nominees? Six impactful discoveries that could be future winners

Targeting ACE2 – Closing COVID-19’s cellular doorway

Since the outbreak of COVID-19, caused by SARS-CoV-2 virus, scientists have been racing to understand it. Extensive research has been devoted to identifying viable genes and proteins as targets for therapeutic agents. One particular protein that has drawn considerable attention is the human cell’s viral receptor, angiotensin-converting enzyme 2 (ACE2).